Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Telsey Advisory Group Maintains Outperform on Williams-Sonoma, Lowers Price Target to $142

Telsey Advisory Group analyst Joseph Feldman maintains Williams-Sonoma (NYSE:WSM) with a Outperform and lowers the price target from $155 to $142.
byBenzinga Newsdesk
March 14, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Telsey Advisory Group analyst Joseph Feldman maintains Williams-Sonoma (NYSE:WSM) with a Outperform and lowers the price target from $155 to $142.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Design Therapeutics To Present Preclinical Data Highlighting The Potential Of Its GeneTAC Small Molecule, DT-216, For The Treatment Of Friedreich Ataxia At International Congress for Ataxia Research 2022 November 3

By Benzinga Newsdesk
October 17, 4:07 PM
Design Therapeutics, Inc. (NASDAQ:DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that preclinical data for the company's novel

DSGN